alpha-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-D-Glcp

Term ID

CHEBI:148586

Synonyms

(2R,3R,4S,5S,6R)-2-[(2R,3S,4S,5R)-4,6-dihydroxy-2-(hydroxymethyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
alpha-D-glucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->2)]-D-glucopyranose
beta-D-gluco-hexopyranosyl-(1->2)-[alpha-D-gluco-hexopyranosyl-(1->4)]-D-gluco-hexopyranose
Glc(b1-2)[Glc(a1-4)]Glc

Definition

A glucotriose that is D-glucopyranose in which the hydroxy groups at positions 2 and 4 have been converted into the corresponding β-D-glucopyranosyl and α-D-glucopyranosyl derivatives, respectively.

References

glygen:G23251MK
glytoucan:G23251MK
kegg.glycan:G09150

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-D-Glcp

Phenotype where environments contain alpha-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-D-Glcp

Phenotype modified by environments containing alpha-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-D-Glcp

Phenotype affecting alpha-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-D-Glcp

Human Disease Model